**Premarket Movers** 1. On Monday, December 15, futures for the three major U.S. stock indices rose. As of writing, Dow futures gained 0.47%, S&P 500 futures climbed 0.50%, and Nasdaq futures advanced 0.50%. 2. European markets also saw gains: Germany’s DAX rose 0.44%, the UK’s FTSE 100 added 0.94%, France’s CAC 40 surged 1.13%, and the Euro Stoxx 50 increased 0.74%. 3. WTI crude fell 0.42% to $57.00/barrel, while Brent crude dipped 0.41% to $60.87/barrel.

**Market Highlights** - **Fed Chair Speculation & Key Data**: Bond markets reacted to potential shifts in Federal Reserve leadership post-Powell, with President Trump suggesting Kevin Hassett or Kevin Warsh as candidates. This week’s economic calendar includes delayed November nonfarm payrolls (Tuesday) and CPI data (Thursday), alongside earnings from Micron (Wednesday) and Accenture, Nike, FedEx, and Darden Restaurants (Thursday). Central bank decisions from the BoE, ECB, and BoJ are also due. - **Bond Market Debate**: Traders are divided over whether the Fed’s 2026 rate-cut cycle will pause or accelerate, with inflation and jobs data critical to resolving the debate. Despite high inflation, markets price in two 2026 rate cuts to support growth. - **BofA’s Bull-Bear Signal**: The Bank of America Bull & Bear Indicator hit 7.8, nearing "extreme bullish" territory, while small-cap inflows and rising risk appetite suggest investors expect a "hot" 2026 economy. - **Hassett on Fed Independence**: White House adviser Kevin Hassett emphasized data-driven policy decisions, stating the Fed would retain independence despite presidential input.

**Commodities & Sector News** - **Copper Rally**: Prices neared $12,000/ton (+35% YTD) on AI-driven data center demand and supply constraints, with Macquarie citing "bullish sentiment fueled by tight supply narratives." - **iRobot (IRBT.US) Bankruptcy**: The Roomba maker filed for Chapter 11 protection, warning shareholders may face total losses. Shares plummeted ~78% premarket. - **STMicroelectronics (STM.US) & SpaceX**: STM has delivered 5B+ chips for Starlink since 2015, with another 5B expected by 2027, highlighting growth in commercial aerospace. - **Sanofi (SNY.US) Setback**: FDA delays and a trial failure for MS drug tolebrutinib (~$1.7B peak sales at risk) drove shares down ~2% premarket. - **Argenx (ARGX.US) Trial Halt**: The thyroid eye disease drug trial termination (Vyvgart) hurt its 2030 patient target. Shares fell ~5% premarket. - **Rocket Lab (RKLB.US) Milestone**: Completed its first dedicated launch for JAXA, with an ESA mission planned in 2026. Shares rose ~2% premarket.

**Key Data & Events Ahead** - 21:30 Beijing: U.S. NY Fed Manufacturing Index - 22:30: Fed Governor Milan speaks - 23:30: NY Fed’s Williams on economic outlook